BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23920309)

  • 1. A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.
    Sweeny L; Hartman YE; Zinn KR; Prudent JR; Marshall DJ; Shekhani MS; Rosenthal EL
    Oral Oncol; 2013 Oct; 49(10):991-7. PubMed ID: 23920309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
    Knowles JA; Golden B; Yan L; Carroll WR; Helman EE; Rosenthal EL
    Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor inhibition by anti-CD147 therapy in cutaneous squamous cell carcinoma.
    Frederick JW; Sweeny L; Hartman Y; Zhou T; Rosenthal EL
    Head Neck; 2016 Feb; 38(2):247-52. PubMed ID: 25270595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD147 and AGR2 expression promote cellular proliferation and metastasis of head and neck squamous cell carcinoma.
    Sweeny L; Liu Z; Bush BD; Hartman Y; Zhou T; Rosenthal EL
    Exp Cell Res; 2012 Aug; 318(14):1788-98. PubMed ID: 22659167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
    Xie J; Li Q; Ding X; Gao Y
    Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma.
    Knowles JA; Heath CH; Saini R; Umphrey H; Warram J; Hoyt K; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):662-8. PubMed ID: 22801891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
    Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
    Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
    Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
    Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab.
    Kumar D; Kandl C; Hamilton CD; Shnayder Y; Tsue TT; Kakarala K; Ledgerwood L; Sun XS; Huang HJ; Girod D; Thomas SM
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1133-9. PubMed ID: 26540318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma.
    Seto K; Shoda J; Horibe T; Warabi E; Ishige K; Yamagata K; Kohno M; Yanagawa T; Bukawa H; Kawakami K
    Oncol Rep; 2013 Jun; 29(6):2147-53. PubMed ID: 23563734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K; Huang Z; Huang Z; He Z; You S
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism.
    Galer CE; Sano D; Ghosh SC; Hah JH; Auzenne E; Hamir AN; Myers JN; Klostergaard J
    Oral Oncol; 2011 Nov; 47(11):1039-47. PubMed ID: 21903450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
    Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
    Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.
    Sweeny L; Liu Z; Lancaster W; Hart J; Hartman YE; Rosenthal EL
    Laryngoscope; 2012 Jul; 122(7):1539-44. PubMed ID: 22460537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
    Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
    Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).
    Zhang F; Li Y; Zhang H; Huang E; Gao L; Luo W; Wei Q; Fan J; Song D; Liao J; Zou Y; Liu F; Liu J; Huang J; Guo D; Ma C; Hu X; Li L; Qu X; Chen L; Yu X; Zhang Z; Wu T; Luu HH; Haydon RC; Song J; He TC; Ji P
    Oncotarget; 2017 Feb; 8(8):12968-12982. PubMed ID: 28099902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.